Journal of ethnopharmacology · 2025
Anticancer potential of iron-based polyherbal formulation against lung and colon cancer cell lines.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Karunamoorthy Kiruthiga, Vasudevan Jaikumar
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Evidence-based research could unlock novel, safe drugs from medicinal plants. Ancient herbal formulations remain largely unproven limits their modern use.
MATERIALS AND METHODS: Following a review of extensive ancient literature, "Kantha Chenduram (KC)" was selected. The current investigation involved a comprehensive characterisation utilising Atomic Force Microscopy, X-ray diffraction, Fourier Transform Infrared Spectroscopy, and Scanning Electron Microscopy with Energy Dispersive X-ray spectroscopic Analysis. Subsequently, the formulation's efficacy was evaluated in vitro against two prevalent lethal cancer cells, namely lung (A549) and colon (HT 29) cancer cells, then through a series of cellular assays, including DNA fragmentation, Fluorescence microscopy, cell cycle studies, and Apoptosis studies. Furthermore, cytotoxicity profile of the formulation was assessed using Vero cells, and its anti-inflammatory potential was investigated.
RESULTS: KC showed crystalline particles, ranging from 200 nm to 7 μm, with the presence of iron and oxygen. Exhibiting potent anticancer activity, the compound showed statistically significant (P < 0.05) IC50 values of 24.75 ± 0.028 μg/mL and 28.8 ± 0.032 μg/mL against lung and colon cancer cell lines, respectively. KC potentially targeted both lung and colon DNA, and fluorescent microscopic studies revealed that apoptotic cells were higher than necrotic cells. Lung cancer cell cycle studies demonstrated G0-G1 phase arrest. Furthermore, Apoptotic studies demonstrated a higher proportion of apoptotic cells in lung (24.33 %) and colon (59.73 %) cancer cells, suggesting a more aggressive cell death pathway. The formulation exhibited a favourable safety profile in Vero cell assays, indicating its safe potential for in vivo administration (P < 0.001). KC evidenced potent anti-inflammatory effects in egg albumin and bovine albumin with IC50 of 73.78 and 81.62 μg/mL, respectively (P < 0.05).
CONCLUSION: These scientific data support the claim that the herbal formulation possesses significant anticancer properties, improving human health. Consequently, the formulation is a promising candidate for clinical trials and global application.
MATERIALS AND METHODS: Following a review of extensive ancient literature, "Kantha Chenduram (KC)" was selected. The current investigation involved a comprehensive characterisation utilising Atomic Force Microscopy, X-ray diffraction, Fourier Transform Infrared Spectroscopy, and Scanning Electron Microscopy with Energy Dispersive X-ray spectroscopic Analysis. Subsequently, the formulation's efficacy was evaluated in vitro against two prevalent lethal cancer cells, namely lung (A549) and colon (HT 29) cancer cells, then through a series of cellular assays, including DNA fragmentation, Fluorescence microscopy, cell cycle studies, and Apoptosis studies. Furthermore, cytotoxicity profile of the formulation was assessed using Vero cells, and its anti-inflammatory potential was investigated.
RESULTS: KC showed crystalline particles, ranging from 200 nm to 7 μm, with the presence of iron and oxygen. Exhibiting potent anticancer activity, the compound showed statistically significant (P < 0.05) IC50 values of 24.75 ± 0.028 μg/mL and 28.8 ± 0.032 μg/mL against lung and colon cancer cell lines, respectively. KC potentially targeted both lung and colon DNA, and fluorescent microscopic studies revealed that apoptotic cells were higher than necrotic cells. Lung cancer cell cycle studies demonstrated G0-G1 phase arrest. Furthermore, Apoptotic studies demonstrated a higher proportion of apoptotic cells in lung (24.33 %) and colon (59.73 %) cancer cells, suggesting a more aggressive cell death pathway. The formulation exhibited a favourable safety profile in Vero cell assays, indicating its safe potential for in vivo administration (P < 0.001). KC evidenced potent anti-inflammatory effects in egg albumin and bovine albumin with IC50 of 73.78 and 81.62 μg/mL, respectively (P < 0.05).
CONCLUSION: These scientific data support the claim that the herbal formulation possesses significant anticancer properties, improving human health. Consequently, the formulation is a promising candidate for clinical trials and global application.